The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time
JAIDS Journal of Acquired Immune Deficiency SyndromesPublished 1 April 2009
Viviane D. Lima, Richard Harrigan, David R. Bangsberg, Robert S. Hogg, Robert Gross, Benita Yip
Citations315
SJR quartileQ1
SJR score1.04
SNIP0.81
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Incomplete adherence to modern HAART over time was strongly associated with increased mortality, and patients on efavirenz-based NNRTI therapies were particularly at a higher risk if nonadherent.
Abstract
Incomplete adherence to modern HAART over time was strongly associated with increased mortality, and patients on efavirenz-based NNRTI therapies were particularly at a higher risk if nonadherent. These results highlight the need to develop further strategies to help sustain high levels of adherence on a long-term basis.
Keywords
Medicine
New England Journal of MedicineDeclining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
9,465 Citations1998Frank J. Palella, Kathleen M. Delaney +6 more
The recent declines in morbidity and mortality due to AIDS are attributable to the use of more intensive antiretroviral therapies.
EpidemiologyMarginal Structural Models and Causal Inference in Epidemiology
5,548 Citations2000James M. Robins, Miguel A. Hernán +1 more
Annals of Internal MedicineGuidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
5,233 Citations1998
Annals of Internal MedicineAdherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
3,328 Citations2000David L. Paterson, Susan Swindells +6 more
Given the critical importance of adherence to therapy to patient outcome, secondary prevention of HIV infection, and willingness of providers to prescribe therapy, this prospectively investigated the association between protease inhibitor adherence and patient outcome and factors related to adherence.
Applied survival analysis: regression modeling of time-to-event data
3,039 Citations2008David W. Hosmer, Stanley Lemeshow +1 more
EpidemiologyMarginal Structural Models to Estimate the Causal Effect of Zidovudine on the Survival of HIV-Positive Men
1,727 Citations2000Miguel A. Hernán, Babette Brumback +1 more
The marginal structural Cox proportional hazards model is described and used to estimate the causal effect of zidovudine on the survival of human immunodeficiency virus-positive men participating in the Multicenter AIDS Cohort Study.
JAMATreatment for Adult HIV Infection
1,036 Citations2006Scott M. Hammer, Michael S. Saag +15 more
The virologic target for patients with treatment failure is now a plasma HIV-1 RNA level below 50 copies/mL, making delivery of state-of-the-art care challenging.
JAMAImproved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy
867 Citations1998Robert S. Hogg
The HIV-infected individuals who receivedInitial therapy with regimens including stavudine or lamivudine had significantly lower mortality and longer AIDS-free survival than those who received initial therapy withregimens limited to zidovudine, didanosine, and zalcitabine.
JAMAA Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients
771 Citations1998Julio Montaner, Peter Reiß +11 more
Triple drug therapy with zidovudine, didanosine, and nevirapine led to a substantially greater and sustained decrease in plasma viral load than the 2-drug regimens studied, suggesting that suppression of viral replication, as demonstrated by a decrease in the plasma HIV-1 RNA load below the level of quantitation of the most sensitive test available, may at least forestall the development of resistance.
JAMARates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy
734 Citations2001Robert S. Hogg
The data demonstrate uniformly low rates of disease progression to death and AIDS or death among patients starting antiretroviral therapy with CD4 cell counts of at least 200/microL, as well as a prior diagnosis of acquired immunodeficiency syndrome (AIDS).
AIDSSociodemographic and psychological variables influencing adherence to antiretroviral therapy
673 Citations1999Victoria Castro Gordillo, Julia del Amo +2 more
Overall, IVDUs and younger individuals tend to have a poorer compliance, as well as subjects with depression and lack of self-perceived social support, which should indirectly improve the effectiveness of antiretroviral therapy.
AIDS CareDeterminants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance
506 Citations1996N. Singh, Cheryl Squier +4 more
The prevalence and variables associated with compliance with antiretroviral therapy in patients with human immunodeficiency virus infection, by means of a longitudinal observational study of 46 patients aged 23 to 68 years, are assessed.
Clinical Infectious DiseasesAssociation between Adherence to Antiretroviral Therapy and Human Immunodeficiency Virus Drug Resistance
483 Citations2003A. K. Sethi, David D. Celentano +3 more
A cumulative adherence of 70%-89%, a CD4 cell nadir of <200 cells/microL, and the missing of a scheduled clinic visit in the past month were independently associated with an increased hazard of viral rebound with clinically significant resistance.
AIDSNatural history of HIV infection in the_era of combination antiretroviral therapy
454 Citations1999Richard D. Moore, Richard E. Chaisson
A significant decline in the incidence of opportunistic illness and death from 1994 through 1998 associated with combination antiretroviral therapy was observed and the concurrent CD4 level was most strongly associated with developing an event.
JAIDS Journal of Acquired Immune Deficiency SyndromesImpact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients
425 Citations2002Patricia García de Olalla, Hernando Knobel +4 more
The modifiable factors most strongly associated with survival were type of treatment and adherence, and it would be desirable to accompany therapy with intervention strategies intended to improve adherence.
AIDSIntermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
425 Citations2002Robert S. Hogg, Katherine Heath +5 more
It is demonstrated that even after adjusting for other prognostic factors intermittent use of antiretroviral therapy was associated with increased mortality, and that those participants who used antireTroviral drugs intermittently were more likely to die.
Annals of Internal MedicineEffect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 10<sup>9</sup> cells/L
363 Citations2003Evan Wood, Robert S. Hogg +4 more
The effect of baseline CD4+ cell count and adherence on survival rates after the initiation of HAART was evaluated and it was suggested that delaying HAART after the CD4- cell count declines below 0.350 109 cells/L may be unsafe.
AIDSLongitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic
321 Citations2002Gregory M. Lucas, Kelly A. Gebo +2 more
This longitudinal study highlights the dynamic nature of substance abuse and its temporal association with the effectiveness of HIV-1 treatment in patients attending an inner-city clinic.
PubMedTreatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.
314 Citations2006Scott M. Hammer, Michael S. Saag +15 more
AIDSAdherence–resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness
313 Citations2006David R. Bangsberg, Edward P. Acosta +6 more
NNRTI resistance was more common than PI resistance at low levels of adherence, and class-specific adherence–resistance relationships are associated with the relative replicative capacity of drug-resistant versus wild-type variants to replicate in the presence of clinically relevant drug levels.
AIDSThe effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART
272 Citations2007Viviane D. Lima, Josie Geller +6 more
The results indicate that both depressive symptoms and adherence were associated with shorter survival among individuals with HIV accessing HAART, and support improvement in the diagnosis and treatment of depression as well as adherence in order to maximize the effectiveness of HAART.
Journal of Antimicrobial ChemotherapyParadoxes of adherence and drug resistance to HIV antiretroviral therapy
269 Citations2004David R. Bangsberg
Current data indicate that each antiretroviral therapeutic class has a unique adherence-resistance relationship, and these dynamic relationships should be considered in balancing the individual and public health benefits of therapy.
AIDSHigh levels of adherence do not prevent accumulation of HIV drug resistance mutations
256 Citations2003David R. Bangsberg, Edwin D. Charlebois +9 more
Increasing rates of viral suppression at high levels of adherence is balanced by increasing rates of drug resistance among viremic patients, which will not prevent population levels ofdrug resistance.
Archives of Internal MedicineLimited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study
253 Citations2001Pythia T. Nieuwkerk
Deviation from the antiretroviral regimen was associated with decreased drug exposure and a decreased likelihood of having suppressed plasma HIV-1 RNA loads, and patient adherence should remain a prime concern in the management of HIV- 1 infection.
Clinical Infectious DiseasesSimilar Adherence Rates Favor Different Virologic Outcomes for Patients Treated with Nonnucleoside Analogues or Protease Inhibitors
222 Citations2004Franco Maggiolo, Laura Ravasio +6 more
Patients receiving NNRTIs report a higher rate of adherence than do patients receiving PIs, and the number of pills and daily doses received correlated with the reported adherence rate.
AIDSEffect of adherence to newly initiated antiretroviral therapy on plasma viral load
217 Citations2001Robert A. Gross, Warren B. Bilker +2 more
Adherence is important in determining whether or not individuals achieve suppression with a newly initiated antiretroviral regimen, particularly after the first month of therapy, and closer assessment of adherence particularly after this first month is important.
JAMAPatient Compliance and Drug Failure in Protease Inhibitor Monotherapy
193 Citations1996Geertrui F. Vanhove
The Journal of Infectious DiseasesA Simple, Dynamic Measure of Antiretroviral Therapy Adherence Predicts Failure to Maintain HIV‐1 Suppression
185 Citations2006Robert Gross, Benita Yip +7 more
The highest levels of antiretroviral therapy adherence are associated with higher rates of maintained virological suppression and this simple, dynamic surrogate measure of adherence overcomes the limitation of single-point-in-time calculations of adherence and may be useful in real time to determine whether an individual is exhibiting incomplete adherence.
JAIDS Journal of Acquired Immune Deficiency SyndromesThe Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO Cohort
183 Citations2001Patrizia Carrieri, Valérie Cailleton +7 more
Adherence behavior is a dynamic process and continued adherence was associated with better response to therapy and should be encouraged to reduce the risk of virologic failure.
AIDS CarePrediction of adherence to antiretroviral therapy: A one-year longitudinal study
167 Citations2005Gaston Godin, José Côté +3 more
A positive attitude towards taking medication was associated with a high level of patient satisfaction with their physician, high perceived social support, being optimistic, living with HIV for five years or less and experiencing no side effects, and interventions aimed at improving adherence to ART were suggested.
JAIDS Journal of Acquired Immune Deficiency SyndromesThe Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected Patients
163 Citations2004Evan Wood, Robert S. Hogg +4 more
These data demonstrate that substantial CD4 gains are possible among highly advanced adherent patients and should contribute to the ongoing debate over the optimal time to initiate HAART.
JAIDS Journal of Acquired Immune Deficiency SyndromesLong-Term Benefits of Highly Active Antiretroviral Therapy in Senegalese HIV-1-Infected Adults
162 Citations2004Christian Laurent, Ndèye Fatou Ngom Gueye +12 more
This study shows that clinical and biologic results similar to those seen in Western countries can be achieved and sustained during the long term in Africa.
Journal of Internal MedicineOne‐year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients
151 Citations2007Wan Beom Park, Pyoeng Gyun Choe +7 more
To determine whether adherence to clinic visits early after initiation of highly active antiretroviral therapy (HAART) is predictive of long‐term clinical outcome, a large number of patients with a history of HIV/AIDS are surveyed.
JAIDS Journal of Acquired Immune Deficiency SyndromesRepeated Measures Longitudinal Analyses of HIV Virologic Response as a Function of Percent Adherence, Dose Timing, Genotypic Sensitivity, and Other Factors
144 Citations2006Honghu Liu, Loren G. Miller +5 more
Long-term viral suppression requires consistent and high percent adherence accompanied by optimal interdose intervals and efforts to improve viral outcomes should address not only missed doses but excessive variation in dose timing and prevention of adherence decline over time.
Clinical Infectious DiseasesAdherence to Highly Active Antiretroviral Therapy in the Homeless Population in San Francisco: A Prospective Study
137 Citations2004Andrew R. Moss, Judith A. Hahn +5 more
One-third of homeless and marginally housed persons receiving HAART discontinued therapy during the follow-up period and would benefit from adherence interventions directed at sustaining therapy; two-thirds continued to receive therapy at adherence levels comparable to those found with other clinical populations.
JAIDS Journal of Acquired Immune Deficiency SyndromesAdherence to Antiretroviral Therapy Among Patients With HIV: A Critical Link Between Behavioral and Biomedical Sciences
111 Citations2002Jeannette R. Ickovics, Christina S. Meade
From this integration of biomedical and behavioral science, effective clinical interventions can be developed and implemented to enhance the health of patients with HIV.
Social Science & MedicineDeterminants of subject compliance within an experimental anti-HIV drug protocol
106 Citations1991Edward V. Morse, Patricia Simon +4 more
Results indicated that more adherent subjects lived further from their treatment site, did not live alone, saw their study nurse as supportive, and were more likely to depend on a significant other for a wide range of social, economic, and emotional support.
Current HIV ResearchAdherence to Antiretroviral Therapies: State of the Science
95 Citations2004Nancy R. Reynolds
A comprehensive review and analysis of the state of the science of a large body of research exploring the problem of adherence to antiretroviral medications, finding Multifaceted strategies appear to be the most promising.
The Journal of Infectious DiseasesRelationship between Adherence and the Development of Resistance in Antiretroviral‐Naive, HIV‐1–Infected Patients Receiving Lopinavir/Ritonavir or Nelfinavir
90 Citations2005Martin King, Scott C. Brun +1 more
Bell-shaped relationships between adherence and resistance were observed, and the risk of detectable HIV-1 RNA loads or of PI or lamivudine resistance was significantly higher in nelfinavir- treated patients than in lopinavir/ritonavir-treated patients.
AIDSExpanding access to HIV antiretroviral therapy among marginalized populations in the developed world
77 Citations2003Evan Wood, Julio Montaner +5 more
Evidence suggests physicians should seek to address modifiable barriers to adherence and retention in HIV treatmentprior to the start of therapy among patients not requiring immediate treatment, and no patient should be denied the opportunity to start HAART regardless of perceived or real barriers to optimal adherence.
PubMedMedication adherence in patients with HIV infection: a comparison of two measurement methods.
75 Citations1999K M Melbourne, Sandra M. Geletko +4 more
Two measurements of adherence, patient self-report and electronic measurement by the Medication Event Monitoring System (MEMS), were compared in a 3-month adherence study of 44 HIV- infected patients who had been placed on regimens that included protease inhibitors (PIs).
The Journal of Infectious DiseasesModeling the HIV Protease Inhibitor Adherence–Resistance Curve by Use of Empirically Derived Estimates
69 Citations2004David R. Bangsberg, Travis C. Porco +6 more
This work statistically modeled the relationship between adherence and development of drug resistance, using empirically defined relationships of the rate of viral suppression and drug-resistance-mutation accumulation derived from patients receiving protease-inhibitor-based therapy.
JAIDS Journal of Acquired Immune Deficiency SyndromesStability of Adherence to Highly Active Antiretroviral Therapy Over Time Among Clients Enrolled in the Treatment Adherence Demonstration Project
67 Citations2003James M. Tesoriero, Tyler French +4 more
Investigation of the stability of adherence over time among HIV-infected individuals attending adherence support programs in New York State found that, for some, it was the transition from a desirable to an undesirable state that increased the likelihood of nonadherence, rather than the presence of these characteristics over time.
JAIDS Journal of Acquired Immune Deficiency SyndromesSatellite Needle Distribution Among Injection Drug Users: Policy and Practice in Two Canadian Cities
59 Citations2002Mark Tyndall, Julie Bruneau +4 more
Access to clean needles and syringes through needle exchange programs (NEPs) has reduced both high‐risk behaviors and the transmission of blood‐borne infections among injection drug users (IDUs).
The Lancet Infectious DiseasesWhen to initiate antiretroviral therapy in HIV-1-infected adults: a review for clinicians and patients
55 Citations2005Evan Wood, Robert S. Hogg +2 more
This work summarises the latest evidence regarding the optimal time to initiate HAART with consideration of the potential benefits and drawbacks of starting HIV treatment at the different levels presently recommended in leading consensus guidelines.
JAIDS Journal of Acquired Immune Deficiency SyndromesAssessing the Effectiveness of Antiretroviral Adherence Interventions
53 Citations2006Maya L. Petersen, Yue Wang +2 more
The implementation of marginal structural models, the assumptions underlying them, and interpretation of results are reviewed, including a theoretic data example in which MSM are used to estimate the effect of a behavioral intervention on adherence to antiretroviral therapy.
Journal of InfectionAdherence, Side Effects and Efficacy of Stavudine plus Lamivudine plus Nelfinavir in Treatment-experienced HIV-infected Patients
47 Citations2000Bernardino Roca, Cayetano J. Gómez +1 more
Overall adherence to the employed HAART regimen was poor and female sex and low baseline HIV RNA were associated with better adherence, which was the main reasons to stop therapy.
The Journal of Infectious DiseasesRates of Disease Progression according to Initial Highly Active Antiretroviral Therapy Regimen: A Collaborative Analysis of 12 Prospective Cohort Studies
38 Citations2006Robert S. Hogg
Outcomes may vary across initial regimens among human immunodeficiency virus type 1-positive persons starting antiretroviral therapy, and there is a need for large, randomized, clinical end-point trials.
Clinical Infectious DiseasesModeling the Impact of Modified Directly Observed Antiretroviral Therapy on HIV Suppression and Resistance, Disease Progression, and Death
25 Citations2004Christopher R. Kagay, Travis C. Porco +6 more
Modified directly observed therapy for human immunodeficiency virus interventions will likely improve clinical outcomes in populations with low levels of adherence but may not be effective at preventing drug resistance in treatment-experienced populations.
The Journal of Infectious DiseasesMillions of Life‐Years Saved with Potent Antiretroviral Drugs in the United States: A Celebration, with Challenges
22 Citations2006Sten H. Vermund
The authors' detailed sensitivity analyses, varying key estimated parameters in their models, indicate that less-conservative assumptions generate an estimate of>5 million years of life saved, a plausible "higher-end" estimate of benefit.
AIDS Patient Care and STDsInitiating Highly Active Antiretroviral Therapy with Newer Protease Inhibitors Is Associated with Better Survival Compared to First-Generation Protease Inhibitors or Nevirapine
9 Citations2007Heidi M. Crane, Stephen E. Van Rompaey +1 more
Significant improvement in survival among patients initiating HAART with newer PIs compared to first-generation PIs or nevirapine is demonstrated, and the complexity of patient factors affecting the clinical outcomes of treatment is highlighted.